Imaging or therapy using administered radiopharmaceuticals. The distribution of the labelled compound selects biological function or tissue, while emitted radiation provides a measurement or deposited energy.
Functional imaging of bone-seeking tracer uptake with a gamma camera or single-photon emission computed tomography. Uptake patterns can reveal abnormal bone turnover.
A position-sensitive detector, usually using a collimator, scintillator and light sensors, that forms a projection image of a gamma-emitting tracer. Energy selection reduces scattered-photon contamination.
A pharmaceutical containing a radionuclide, with uptake and clearance chosen for imaging or treatment. Biological targeting and radioactive decay jointly determine its useful signal and tissue dose.
An iodine radionuclide with approximately eight-day half-life, emitting beta particles and gamma rays. Its uptake and retention depend strongly on the carrier and tissue physiology.
Radioiodide used in selected thyroid treatments because iodine uptake localizes activity in thyroid tissue. Iodine-131 supplies local beta radiation and imageable gamma emission.
A diagnostic bone tracer combining technetium-99m with a diphosphonate carrier. Uptake reflects bone turnover and delivery, rather than a unique disease diagnosis.
A metastable nuclear isomer used in diagnostic tracers, with approximately six-hour half-life and imageable gamma rays. Its chemical carrier determines biological uptake.
Articles by others on the same topic
Nuclear medicine is a specialized field of medical imaging and therapy that utilizes radioactive materials, or radiopharmaceuticals, for diagnosis and treatment of various health conditions. It involves the use of small amounts of radioactive substances to carry out imaging and therapeutic procedures. ### Diagnostic Uses In diagnostic applications, nuclear medicine techniques can visualize the function of organs and tissues.